'Johnson &amp; Johnson announced of a deal with the African Vaccine Acquisition Trust (AVAT) to bring relief to that continent. AVAT has an initial deal for 220 million doses of the single-shot vaccine with J&amp;J subsidiary Janssen Pharmaceutica for delivery from the third quarter....'